Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of aliskiren alone and in combination with ramipril in hypertensive patients with diabetes; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)
  • Ramipril (ramipril)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Diabetes Mellitus | Phase 3 | Status: COMPLETED